RE:Ed Nash just incriminated himself... I thought it was as part of the discussion about getting data out as fast as possible, that he knew this to be the case and was essentially urging Paul to release data ASAP. Paul seemed to confirm summer (my expectation late summer) for safety and efficacy afterwards. I think he talked about a couple of data points in regard to efficacy, I think all he's talking about there is the first tumour shrinkages and then follow on scans that confirm the first findings, maybe something that rises to the level of Partial Response, that's a more meaningful finding. That seems to be how it works with other biotech. It sounds like once they think they have something solid they will go public not too much delay.
Wino115 wrote: I don't think he realized his comment on how he needs to focus more on oncology (paraphrase) because in unmet needs, small improvements have huge financial implications showed either his inexperience or inability to look forward and be proactive (or laziness). A decent analysts already knows this -- it's obvious if you know the industry. We've been yelling about that for a few months now! He shoudl be embarassed.